How to Buy Vertex Pharmaceuticals Stock
Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis.
Vertex Pharmaceuticals stock last closed at $455.48, down 0.41% from the previous day, and has decreased 0.97% in one year. It has overperformed other stocks in the Biotechnology industry by 0.46 percentage points. Vertex Pharmaceuticals stock is currently +25.65% from its 52-week low of $362.50, and -12.35% from its 52-week high of $519.68.
There are currently 253.72M VRTX shares outstanding. The market capitalization of VRTX is $115.56B. In the last 24 hours, 911,000 VRTX shares were traded.
How to Buy Vertex Pharmaceuticals Stock
Wondering how to invest in Vertex Pharmaceuticals stock? Here's how.
- Decide where to buy Vertex Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you choose where to buy Vertex Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Select your method of payment and add your info.
- Research Vertex Pharmaceuticals stock: The Vertex Pharmaceuticals ticker symbol is VRTX. Is Vertex Pharmaceuticals stock a good investment? Should you buy shares of VRTX? How do VRTX's underlying business fundamentals look? Do top analysts think Vertex Pharmaceuticals is a good buy? Why has VRTX's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if VRTX is a good stock to buy).
- Execute your VRTX purchase: Decide if you will purchase VRTX shares at the current market price or use a limit order to buy VRTX stock at a given price.
- Get the latest scoop on your investment in VRTX: Create a watchlist to important updates regarding your position in Vertex Pharmaceuticals stock.
Step 1: Decide where to buy Vertex Pharmaceuticals stock
You will need an online brokerage account to access the NASDAQ market and buy VRTX shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal info so you are able to invest in VRTX stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open a new trading account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've finished signing up on the best stock market app for beginners, you need to deposit funds:
Watch the walkthrough below for more details transferring funds into your new brokerage account.
Step 4: Research Vertex Pharmaceuticals stock
After you have selected the best place to buy Vertex Pharmaceuticals stock, it's important to research their stock before you buy, so you can comprehend the risk and opportunity.
Vertex Pharmaceuticals Metrics
Fundamentals of VRTX
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on VRTX's stock page.
Is VRTX stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge VRTX's intrinsic value.
Using relative valuations ratios:
- VRTX may be undervalued based on its P/E ratio of 31.83x, relative to Biotechnology industry P/E ratio of 186.51x
- VRTX may be overvalued based on its P/B ratio of 6.67x, relative to Biotechnology industry P/B ratio of 5.29x
- VRTX may be overvalued based on its PEG ratio of 1.92x
You can access more valuation research on VRTX's stock here.
VRTX Financial Overview
Pros:
- VRTX earnings of $4.46B is not sufficient to cover its interest payments.
- VRTX profit margin has gone up from -4.5% to 31.3% in the past year.
- VRTX's operating cash flow of $3.72B allows it to safely service it's debt of $1.83B.
- There are more short-term assets than short-term liabilities on the VRTX balance sheet.
- There are more short-term assets than long-term liabilities on the VRTX balance sheet.
Cons:
- Total VRTX debt is higher than 5 years ago, relative to shareholder equity.
- VRTX has a relatively high debt to equity ratio of 0.44.
Do Wall Street analysts think it's a good time to buy VRTX stock
Out of 19 sell side analysts who give ratings on VRTX, the consensus analyst rating on VRTX is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent VRTX Analyst Forecasts
Jessica Fye, a top 4% analyst from JP Morgan maintains VRTX with a strong buy rating and raises their VRTX price target from $517.00 to $530.00, on Oct 8, 2025.
Geoff Meacham, a top 12% analyst from Citigroup maintains VRTX with a strong buy rating and raises their VRTX price target from $550.00 to $575.00, on Oct 2, 2025.
Citigroup's Geoff Meacham raised their price target on Vertex Pharmaceuticals (NASDAQ: VRTX) by 4.5% from $550 to $575 on 2025/10/02. The analyst maintained their Strong Buy rating on the stock.
After incorporating povetacicept into their Vertex Pharmaceuticals model, Meacham said they raised their price target.
Footnotes
Povetacicept is an investigational biologic therapy designed to modulate the immune system, particularly in autoimmune and kidney-related diseases
David Risinger, a top 10% analyst from Leerink Partners upgrades VRTX to a buy rating and lowers their VRTX price target from $458.00 to $456.00, on Sep 25, 2025.
Liisa Bayko, a top 10% analyst from Evercore ISI Group maintains VRTX with a buy rating and lowers their VRTX price target from $510.00 to $475.00, on Sep 11, 2025.
Whitney Ijem, a top 4% analyst from Canaccord Genuity maintains VRTX with a hold rating and lowers their VRTX price target from $424.00 to $411.00, on Aug 6, 2025.
You can dig deeper into what analysts are projecting on the Vertex Pharmaceuticals stock forecast page.
Metrics for Advanced VRTX Traders
Is VRTX Growing Revenue?
Last year, VRTX earnings were $3.68B. In the last five year, VRTX's earnings have gone up by 6.67% per year. This was slower than the Biotechnology industry average of 10.87%.
Last year, VRTX revenue was $11.72B. Over the past five year, VRTX's revenue has grown by 14.37% per year. This was slower than the Biotechnology industry average of 44.12%.
Dive into VRTX's earnings and revenue performance here.
Latest Insiders Trades at VRTX
In the last 12 months, executives and large shareholders at VRTX have sold more shares than they have bought.
Jeffrey M. Leiden, Executive Chairman of VRTX, was the latest VRTX insider to buy. They bought $91.05 worth of VRTX shares on Dec 4, 2025.
Learn more about who owns VRTX stock here.
Can I rely on VRTX as an income stream?
No, Vertex Pharmaceuticals doesn't provide an income stream by paying out dividends.
VRTX Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your VRTX purchase
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open Trade button and your broker will place your order.
If you want additional help with investing in stocks on eToro, click the how to video below:
Step 6: Get the latest scoop on your investment in VRTX
Now that you own some shares in VRTX, you'll want to stay up-to-date on your investment.
Create a watchlist to monitor your VRTX stock.
VRTX Feed
How to Buy Stock in Vertex Pharmaceuticals
To summarize, here are the 6 steps for buying Vertex Pharmaceuticals stock:
- Decide where to buy Vertex Pharmaceuticals stock
- Create your brokerage account
- Put funds into your brokerage account
- Research Vertex Pharmaceuticals stock
- Execute your VRTX purchase
- Get the latest scoop on your investment in VRTX
If you need a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep track of your investment in Vertex Pharmaceuticals, click below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.